This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 49/5/1120    most recent HYPERTENSIONAHA.106.077537v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koitabashi, N. Articles by Kurabayashi, M. Search for Related Content PubMed PubMed Citation Articles by Koitabashi, N. Articles by Kurabayashi, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cardiomyopathy Related Collections Other myocardial biology Remodeling Hypertrophy Physiological and pathological control of gene expression

(Hypertension. 2007;49:1120.)
© 2007 American Heart Association, Inc.

Original Articles

Increased Connective Tissue Growth Factor Relative to Brain Natriuretic Peptide as a Determinant of Myocardial Fibrosis

Norimichi Koitabashi; Masashi Arai; Shinya Kogure; Kazuo Niwano; Atai Watanabe; Yasuhiro Aoki; Toshitaka Maeno; Takashi Nishida; Satoshi Kubota; Masaharu Takigawa; Masahiko Kurabayashi

From the Department of Medicine and Biological Science (N.K., M.A., S.K., K.N., A.W., Y.A., T.M., M.K.), Gunma University Graduate School of Medicine, Gunma, Japan; and the Department of Biochemistry and Molecular Dentistry (T.N., S.K., M.T.), Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Correspondence to Masashi Arai, Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. E-mail araim{at}showa.gunma-u.ac.jp

Excessive fibrosis contributes to an increase in left ventricular stiffness. The goal of the present study was to investigate the role of connective tissue growth factor (CCN2/CTGF), a profibrotic cytokine of the CCN (Cyr61, CTGF, and Nov) family, and its functional interactions with brain natriuretic peptide (BNP), an antifibrotic peptide, in the development of myocardial fibrosis and diastolic heart failure. Histological examination on endomyocardial biopsy samples from patients without systolic dysfunction revealed that the abundance of CTGF-immunopositive cardiac myocytes was correlated with the excessive interstitial fibrosis and a clinical history of acute pulmonary congestion. In a rat pressure overload cardiac hypertrophy model, CTGF mRNA levels and BNP mRNA were increased in proportion to one another in the myocardium. Interestingly, relative abundance of mRNA for CTGF compared with BNP was positively correlated with diastolic dysfunction, myocardial fibrosis area, and procollagen type 1 mRNA expression. Investigation with conditioned medium and subsequent neutralization experiments using primary cultured cells demonstrated that CTGF secreted by cardiac myocytes induced collagen production in cardiac fibroblasts. Further, G protein-coupled receptor ligands induced expression of the CTGF and BNP genes in cardiac myocytes, whereas aldosterone and transforming growth factor-ß preferentially induced expression of the CTGF gene. Finally, exogenous BNP prevented the production of CTGF in cardiac myocytes. These data suggest that a disproportionate increase in CTGF relative to BNP in cardiac myocytes plays a central role in the induction of excessive myocardial fibrosis and diastolic heart failure.

Key Words: extracellular matrix • hypertrophy • cardiac function • connective tissue growth factor • natriuretic peptide

This article has been cited by other articles:

				J. Zagorski, M. Obraztsova, M. A. Gellar, J. A. Kline, and J. A. Watts Transcriptional changes in right ventricular tissues are enriched in the outflow tract compared with the apex during chronic pulmonary embolism in rats Physiol Genomics, September 1, 2009; 39(1): 61 - 71. [Abstract] [Full Text] [PDF]

				J. Meyer-Kirchrath, M. Martin, C. Schooss, C. Jacoby, U. Flogel, A. Marzoll, J. W. Fischer, J. Schrader, K. Schror, and T. Hohlfeld Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart Cardiovasc Res, February 1, 2009; 81(2): 310 - 318. [Abstract] [Full Text] [PDF]

				R. F. Duisters, A. J. Tijsen, B. Schroen, J. J. Leenders, V. Lentink, I. van der Made, V. Herias, R. E. van Leeuwen, M. W. Schellings, P. Barenbrug, et al. miR-133 and miR-30 Regulate Connective Tissue Growth Factor: Implications for a Role of MicroRNAs in Myocardial Matrix Remodeling Circ. Res., January 30, 2009; 104(2): 170 - 178. [Abstract] [Full Text] [PDF]

				N. Koitabashi, M. Arai, K. Niwano, A. Watanabe, M. Endoh, M. Suguta, T. Yokoyama, H. Tada, T. Toyama, H. Adachi, et al. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure Eur J Heart Fail, April 1, 2008; 10(4): 373 - 379. [Abstract] [Full Text] [PDF]

				B. Burstein, A. Maguy, R. Clement, H. Gosselin, F. Poulin, N. Ethier, J.-C. Tardif, T. E. Hebert, A. Calderone, and S. Nattel Effects of Resveratrol (trans-3,5,4'-Trihydroxystilbene) Treatment on Cardiac Remodeling following Myocardial Infarction J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 916 - 923. [Abstract] [Full Text] [PDF]